Parkinsonism & Related Disorders
Volume 16, Issue 5 , Pages 316-323, June 2010

Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia☆☆☆

  • Daniel Truong

      Affiliations

    • The Parkinson’s and Movement Disorder Institute, 9940 Talbert Avenue, #204, Fountain Valley, CA 92708, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 714 378 5062; fax: +1 714 378 5061.
    • ,
  • Matthew Brodsky

      Affiliations

    • Oregon Health & Science University, Portland, OR, USA
    • ,
  • Mark Lew

      Affiliations

    • Keck/University of Southern California School of Medicine, University of Southern California, Los Angeles, CA, USA
    • ,
  • Allison Brashear

      Affiliations

    • Wake Forest University Health Sciences, Department of Neurology, Winston-Salem, NC, USA
    • ,
  • Joseph Jankovic

      Affiliations

    • Department of Neurology, Parkinson’s Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, TX, USA
    • ,
  • Eric Molho

      Affiliations

    • Parkinson’s Disease and Movement Disorders Center, Albany Medical Center, Albany, USA
    • ,
  • Olga Orlova

      Affiliations

    • Moscow Medical Academy and Academy Clinic of Neurology and Stomatology Cecil-plus, Moscow, Russia
    • ,
  • Sofia Timerbaeva

      Affiliations

    • Research Center of Neurology, Russian Academy of Medical Sciences, Moscow, Russia
    • ,
  •  On behalf of the Global Dysport Cervical Dystonia Study Group

      Affiliations

    • Members of the Global Dysport Cervical Dystonia Study Group were: Dr. S. Aurora (Seattle, USA), Dr. A. Brashear (Winston-Salem, USA), Dr. M. Brodsky (Portland, USA), Dr. A. Ahmed (Phoenix, USA), Dr. C. Comella (Chicago, USA), Dr. D. Dykstra (Minneapolis, USA), Dr. M. Evatt (Atlanta, USA), Dr. H. Fernandez (Gainesville, USA), Dr. J. Jankovic (Houston, USA), Dr. P. Jozefczyk (Pittsburgh, USA), Dr. M. Lew (Los Angeles, USA), Dr. E. Molho (Albany, USA), Professor O. Orlova (Moscow, Russian Federation), Dr. P. O’Suilleabhain (Dallas, USA), Dr. S. Perfiliev (St. Petersburg, Russian Federation), Dr. R. Rodnitzky (Iowa City, USA), Dr. C. Singer (Miami, USA), Professor A. Skoromets (St. Petersburg, Russian Federation), Dr. S. Timerbaeva (Moscow, Russian Federation) and Dr. D. Truong (Fountain Valley, USA).

Received 11 November 2009; received in revised form 4 February 2010; accepted 7 March 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ The review of this paper was entirely handled by the Co-Editor-in-Chief, Ronald Pfeiffer.

☆☆ Clinical trials information: (NCT00257660 and NCT00288509; clinicaltrials.gov).

PII: S1353-8020(10)00055-6

doi:10.1016/j.parkreldis.2010.03.002

Parkinsonism & Related Disorders
Volume 16, Issue 5 , Pages 316-323, June 2010

Article Tools

* Image Usage & Resolution